HMD reaches milestone of supplying 500 million 0.5 ml AD syringes to government for COVID vaccination

The next lot of 16.3 million syringes has been inspected and is ready to dispatch

Hindustan Syringes & Medical Devices (HMD) has achieved another milestone of supplying 500 million 0.5 ml AD syringes to government to help vaccinate over 685 million people till date to support the massive vaccination campaign to eradicate COVID-19 and help make India Atmanirbhar.

The next lot of 16.3 million syringes has been inspected and is ready to dispatch.

In our endeavor “to ensure there is no shortage of syringes to help vaccinate India against COVID, HMD has preponed the supply commitments to the Ministry of Health and Family Welfare and has supplied 500 million pcs of KOJAK AD Syringes to GoI to help vaccinate over 685 million people. HMD presently is not accepting new business export opportunities from many overseas buyers and also had earlier diverted the supply of 100 million pcs from UNICEF order to GoI from Sept to Dec. HMD will always prioritize domestic needs, Sorry if it wasn’t enough. Regret Government has had to partly restrict exports, we all could have planned better”, shared Rajiv Nath, Managing Director of Hindustan Syringe & Medical Device Ltd (HMD).

“Total Govt orders HMD received till date from Dec 2020 are of 753.10 million pcs of 0.5 ml Kojak AD Syringes. In addition HMD has been supplying most of the 1 ml / 2 ml DispoVan & 0.5 ml / 2 ml Kojak AD Syringes (approx 50 million syringes) being used in the private sector vaccination campaign.  All orders received from December till date have been supplied on time or before time as committed”, added Nath.

HMD is on track to produce & supply outstanding orders of 310 million 0.5 ml KOJAK AD syringes by 2022 beginning, hopefully by January end.

“We feel humbled & honoured to contribute to the National vaccination campaign & Union Health Ministry’s plans to celebrate India administering 1 billion Covid vaccine doses by October. The vaccine bullets need our guns. It is a huge responsibility”, said Nath.

“HMD’s manufacturing plants are operational 24/7. It’s a race against time to help ramp up capacity of our Cannulas (Needle Points) & Needle Capillary Tubing Manufacturing. A new 150,000 sq ft factory as a green field project is set to be commissioned by Jan 2022 to increase capacity from 4 billion Cannulas (Needle points) per annum to 6 billion per annum to be Atmanirbhar, a vision we share with the Honorable Prime Minister. Presently, HMD is producing more than 4.25 lakh syringes of various types per hour at our factories spread over 11 acres in Faridabad industrial district in Haryana.” stated Nath, who is also referred as Make in India Man of Medical Devices.

“We again request The Union government to place orders for Syringes with the manufacturers in India well in advance so that the latter could ramp up supplies or allocate supplies for GoI. Clarity should be given of India’s quarterly needs by MoH&FW for calendar year 2022 as we can’t plan on a 2-4 months window horizon basis. To ramp up capacity, we need an order confirmation at least nine months to a year in advance.”

“India’s vaccination drive has been a role model for the world. We congratulate the Indian Government & we are glad we could shoulder the responsibilities with the Govt. for the success of India’s massive vaccination campaign, while balancing ongoing market needs for seasonal spike of Dengue & Typhoid” said Pradeep Sareen, Marketing Head of Hindustan Syringes & Medical Devices

“In line with PM Modi’s plans to resume export of surplus COVID-19 vaccines in the fourth quarter of 2021 in order to fulfill the commitment of India towards COVAX, we at HMD are confident that India will also be in a position to export some Covid vaccine syringes as part of ‘Vaccine & Syringe Maitri’ to fulfill India’s commitment towards the world for the collective fight against COVID-19. No One is Safe until Everyone is Safe”, Nath.

HMD extends full cooperation & support to Government of India and will do whatever it needs to produce syringes ahead of schedule to ensure success of India’s massive vaccination campaign” assured Nath